Lawrence C. Newman, MD, of Mount Sinai Roosevelt Elected New President of The American Headache Society
Neurologist is Also Director of The Headache Institute at Mount Sinai Roosevelt
Lawrence C. Newman, MD, director of The Headache Institute and an attending neurologist at Mount Sinai Roosevelt, has been elected president of the American Headache Society (AHS), the professional society of more than 1,500 health care providers dedicated to the study and treatment of headache and face pain.
Dr. Newman is a professor of neurology at the Icahn School of Medicine at Mount Sinai. Board certified in neurology, Dr. Newman was one of the first in the nation to have completed a formal fellowship in headache, and has since trained many headache specialists in the subspecialty of Headache Medicine. He is also one of some 400 physicians in the country with Board Certification in Headache Medicine.
“I look forward to serving as President of AHS for the next two years. During my tenure, I hope to work closely with our membership to meet their needs and I hope to build upon the successes of our organization and to strengthen our bonds with regional headache societies as well,” says Dr. Newman. “I believe that AHS is and must remain the premier source of headache education in the country for clinicians and patients. Since migraine is a life-long disorder, I hope to promote awareness of pediatric and adolescent headache disorders so that we can take steps to identify and treat young people early to avoid needless suffering later in life. Because headache is a prominent symptom of concussion and other forms of traumatic brain injury, I believe AHS must become the cornerstone of information, education, and research in these areas. Headache research is woefully underfunded, so it is imperative that AHS, through legislative and other avenues, act to correct this disparity. “
Under Dr. Newman’s leadership, The Headache Institute at Mount Sinai Roosevelt was recently selected as one of only 10 headache centers in the United States to earn the National Institutes of Health (NIH) Center of Excellence Designation. Founded in 1998, the Headache Institute is dedicated solely to treating recurrent head or facial pain. Highly qualified, board certified neurologists conduct cutting-edge research to expand understanding of how and why headaches occur. Every attending physician at The Headache Institute has done a fellowship in headache, stroke and/or directed other renowned headache programs during the last 20 years. For more information or to make an appointment, please call: 212-523-5869
“The American Headache Society’s appointment of Dr. Newman as their new president is a testament to his proven track record of leadership excellence, clinical acumen and commitment to be at the forefront of the field of headache medicine,” says Stuart Sealfon, Chairman of the Department of Neurology for Mount Sinai Health System. “As founding director of The Headache Institute, Dr. Newman has improved the lives of thousands of headache patients in the New York area. His expertise and experience will now be expanded to have an impact on clinicians and patients across the country. I offer my congratulations to our esteemed colleague on this prestigious honor.”
Dr. Newman has authored or co-authored more than 30 original publications as well as monographs and book chapters on various aspects of migraine medicine and other headache disorders. He is a Fellow of the American Academy of Neurology and the American Headache Society. Dr. Newman is a member of the International Headache Society and serves on the Executive Board of the Headache Cooperative of New England.
Founded in 1959, the American Headache Society is a professional society of health care providers dedicated to the study and treatment of headache and face pain. The Society’s objectives are to promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders. Educating physicians, health professionals and the public and encouraging scientific research are the primary functions of this organization. AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, publication of the journal Headache and sponsorship of the AHS Committee for Headache Education (ACHE). For more information, please visit: www.americanheadachesociety.org
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.